Current Funds
Activate Networks applies social network analytics to influence behavior of healthcare providers and patients to enhance wellness.
Status: Acquired by Decision Resources Group
Aileron Therapeutics is developing stapled peptides, an entirely new therapeutic modality that can target all human diseases.
Status: Public (ALRN), rebranded to Rein Therapeutics (Nasdaq: RNTX)
Aventura has developed technology that dramatically increases the efficiency and effectiveness of doctors by offering context and location-aware computing.
Status: Acquired by Phillips
Biocius Life Sciences provides the pharmaceutical industry with mass spectrometer related products to accelerate drug discovery and development.
Status: Acquired by Agilent Technologies
Biotrove provides micro and nano-scale technologies to serve research and diagnostics markets in healthcare and beyond.
Status: Acquired by Life Technologies (LIFE)
Catch is a leading provider of smartphone and productivity applications that capture, organize, and share information.
Status: Acquired by Apple
ClearDATA provides cloud computing infrastructure and managed services to healthcare provider and technology companies.
Status: Private
Cleveland HeartLab is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests.
Status: Acquired by Quest Diagnostics
Zipongo dba Foodsmart is a mobile phone-enabled wellness system providing a way for employers to empower employees to make smart decisions about the food they eat at work and at home
Status: Private
Gemphire Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing gemcabene for the treatment of dyslipidemia.
Status: Acquired by NeuroBo Pharmaceuticals
IlluminOss is a medical device company dedicated to bringing to market minimally invasive solutions for the stabilization and treatment of bone fractures.
Status: Private
InfoBionic is a IT-enabled remote monitoring system that has developed a platform for the diagnosis and monitoring of cardiac arrhythmias
Status: Private
MedVentive works with leader provider and payer organizations to develop and deploy innovative approaches to successfully reduce healthcare costs and improve outcomes.
Status: Acquired by McKesson (MCK)
NanoMR has developed the first system for rapid detection of rare cells from complex matrices that can target multiple cell types simultaneously.
Status: Acquired by DNA Electronics
N-of-One is a personalized health IT and diagnostic interpretation company that provides oncologists with clinically actionable interpretation of genetics mutations that exist in a patient’s tumor
Status: Acquired by Qiagen
Openwater is developing a new generation of imaging technologies, with high resolution and low costs, enabling medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications
Status: Private
Orionis Biosciences is a clinical stage therapeutics company reprogramming biology with breakthrough precision to cure disease. Its initial product pipeline is focused on immuno-oncology.
Status: Private
Qstream is a software as a service (SaaS) sales enablement and analytics company that has developed a mobile, social sales training tool for some of the world’s largest companies
Status: Private
Saladax is a diagnostics platform company providing personalized cancer drug monitoring to improve outcomes for cancer patients on chemotherapy
Status: Private
ShapeUP uses the power of social networks, behavioral change science, and engaging technology to enhance the lives of employees around the world.
Status: Acquired by Virgin Pulse, merged with HealthComp and rebranded as Personify Health
Synthetic Genomics is a synthetic biology company that uses its propriety technology to design and build biological systems solving global sustainability challenges
Status: Spun out two companies, remainder was acquired by Breakthrough Energy Ventures
Tetraphase Pharmaceuticals is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics
Status: Public (TTPH), acquired by La Jolla Pharmaceutical Company
Virgin Pulse, a leading provider of employee-centric solutions that drive wellbeing, culture and productivity across organizations around the world
Status: Private; Acquired by Marlin Equity Partners
Welldoc is developing next generation technology solutions to support chronic disease management, specifically in diabetes
Status: Private
